William G Kearns

Co-Founder, CEO & Chief Scientific Officer, Genzeva, LumaGene; Johns Hopkins University School of Medicine, Genetics, and MIT, Artificial Intelligence, Biomimetic Digital Twins

View articles by William G Kearns

Everyone needs SARS-CoV-2 virus testing

Everyone needs SARS-CoV-2 virus testing

April 24, 2020

11 likes

AdvaGenix announces a Multiplex RT-PCR Kit with Targeted Specificity to 100% of COVID-19 Sequences

AdvaGenix announces a Multiplex RT-PCR Kit…

April 6, 2020

16 likes1 comment

Why Should Doctor's order Inherited Cancer Gene Panels?

Why Should Doctor's order Inherited Cancer…

September 20, 2019

9 likes2 comments

AdvaGenix Launches Whole Genome Sequencing

AdvaGenix Launches Whole Genome Sequencing

July 28, 2017

29 likes2 comments

AdvaGenix Launches 323 Gene Preconception Carrier Screening Panel for over 700 Inherited Diseases

AdvaGenix Launches 323 Gene Preconception…

July 10, 2017

25 likes

AdvaGenix Launches Enhanced Clinical Exome Diagnostics

AdvaGenix Launches Enhanced Clinical Exome…

July 10, 2017

25 likes

AdvaGenix Will Offer First FDA Approved Next Generation Sequencing Test To Screen Tumor Samples For Markers Associated With Therapies

AdvaGenix Will Offer First FDA Approved Next…

June 24, 2017

19 likes

AdvaGenix Launches Inherited Cancer Gene Testing

AdvaGenix Launches Inherited Cancer Gene…

June 24, 2017

30 likes3 comments

What is the incidence of clinically significant dels and dups in preimplantation embryos as determined by enhanced next generation sequencing?

What is the incidence of clinically…

October 14, 2016

11 likes1 comment

Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences?

Preimplantation genetic testing for…

July 23, 2016

15 likes